PEN earnings date and last-quarter result: last quarter beat, P/E 72.26. Updated 2026-07-23.
Penumbra (PEN) Research Hub
Penumbra (PEN) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 325.22 USD (+0.26%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 72.26, market cap 12.46B. This hub links to the full technical, earnings and options research available for PEN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 325.22 USD (+0.26%) |
| 52-week range | 314.8 USD – 327.77 USD |
| Trend regime | Range |
| 14-day RSI | 77.5 (Overbought) |
| Trailing P/E | 72.26 |
| Market cap | 12.46B |
| Dividend yield | 0.00% |
Available research for PEN
Covered Call on PEN: how it works, illustrative setup around the real 325.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PEN: how it works, illustrative setup around the real 325.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PEN: how it works, illustrative setup around the real 325.22 USD price, max profit/loss, breakeven and when to use it. Educational.
PEN technical analysis: range, last 325.22 USD, RSI 77.5, 52w range 314.8 USD–327.77 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PEN in?
Penumbra (PEN) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is PEN in an uptrend or downtrend?
As of 2026-10-26, PEN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PEN's trailing P/E ratio?
PEN's trailing P/E is 72.26, with a market cap of 12.46B. See the earnings research page for full valuation detail.